WHITEBOX ADVISORS LLC - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K113. A total of 44 filers reported holding PHOENIX BIOTECH ACQUISITION in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WHITEBOX ADVISORS LLC ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q3 2023$1,790
+17.1%
25,0000.0%0.00%
Q2 2023$1,528
+52.3%
25,0000.0%0.00%
Q1 2023$1,003
-7.0%
25,0000.0%0.00%
Q4 2022$1,078
-46.1%
25,0000.0%0.00%
Q3 2022$2,000
-33.3%
25,0000.0%0.00%
Q2 2022$3,000
-40.0%
25,0000.0%0.00%
Q1 2022$5,000
-54.5%
25,0000.0%0.00%
Q4 2021$11,00025,0000.00%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q2 2022
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 163,538$1,636,0000.09%
Telemetry Investments, L.L.C. 121,614$23,0000.04%
Radcliffe Capital Management, L.P. 150,000$1,501,0000.03%
Q Global Advisors, LLC 170,785$37,0000.02%
CANTOR FITZGERALD, L. P. 363,548$79,0000.01%
Atalaya Capital Management LP 225,000$50,0000.01%
MMCAP International Inc. SPC 375,000$82,0000.01%
Bulldog Investors, LLP 54,745$11,0000.00%
NEXPOINT ASSET MANAGEMENT, L.P. 108,741$24,0000.00%
Context Capital Management, LLC 200,000$44,0000.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders